Article may be outdated

This article is 5 days old. Some details may have changed since publication.

The Hindu·2 min read·hard

New blood test finds early risk for ovarian cancer

R
Reuters
New blood test finds early risk for ovarian cancer
✦AI Summary

Researchers have identified a molecular signal in the blood, specifically an RNA molecule called Tu-Stroma, that can detect early-stage ovarian cancer. This breakthrough could allow for earlier intervention before invasive cancer develops, potentially transforming preventative care for high-risk women.

Why it matters

Early detection of ovarian cancer is notoriously difficult, and this diagnostic tool could significantly improve survival rates and reduce the need for unnecessary preventative surgeries.

✦Dive DeeperCreate a free account to unlock

A molecular signal in the blood helps identify microscopic changes that precede the development of ovarian cancer, researchers have found, in a potential diagnostic breakthrough for a disease often discovered after it has already spread. For decades, efforts to detect ovarian cancer earlier have focused on finding smaller tumours, the researchers noted in their report published on Tuesday in Nature Medicine. “We asked a fundamentally different question: What if we could identify the earliest molecular warning signs before invasive cancer even develops?” study leader Rajan Gogna of the Hoag Family Cancer Institute in Newport Beach, California, said in a statement. Ovarian cancer often begins with microscopic changes in the lining of the fallopian tubes. The precancerous lesions are known as serous tubal intraepithelial carcinoma (STIC).

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthsciencetechnology
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in